UnitedHealth Group’s shares saw a significant drop of over 15% in early trading on Thursday.
This downturn adds to the ongoing troubles faced by health insurance companies, including various government inquiries, unexpected leadership changes, and pressures due to increasing health costs.
Investors and analysts pointed out that, while specific details about the latest survey were sparse, it heightened their concerns.
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| UNH | UnitedHealth Group Inc. | 264.09 | -43.87 | -14.25% |
Following the uncertainty, James Harlow, a senior vice president at Novare Capital Management, remarked, “The stocks are already in the kennels with investors, and the additional uncertainty is just piling up.”
Despite the turmoil, the company stated it hadn’t received any notifications from the Department of Justice concerning the rumored criminal investigation.
This news comes right after the unexpected departure of CEO Andrew Witty and the withdrawal of future forecasts, leading to shares plummeting by 18% on Tuesday.
Susannah Streeter, head of money and markets at Hargreaves Lansdown, commented, “UnitedHealth Group is in a seemingly never-ending crisis. Investors are faced with more turbulence following reports on the DOJ investigation.”
If the early losses persist, UnitedHealth’s market cap would drop to around $280 billion, nearly half of the $500 billion it was valued at on April 16th.
Government scrutiny of the health insurance sector escalated this month with a lawsuit accusing three major U.S. insurers of paying kickbacks to brokers, directing patients towards specific plans.
Earlier in February, a civil fraud investigation into UnitedHealth’s Medicare practices was revealed, prompting U.S. Senator Chuck Grassley to request a detailed compliance report and initiate further investigation into the company’s claims.
Throughout its history, the company has thrived by capitalizing on the growing Medicare market, which covers health expenses for seniors.
However, its strong track record has come under pressure after the tragic death of a senior executive, allegedly at the hands of someone enraged by the company’s practices.
